A retrospective study of first-line combination chemotherapy in advanced colorectal cancer A Korean single-center experience.

被引：0
|
作者：
Lee, S.
Park, J.
Park, S.
Kang, W.
Lim, H.
Park, Y.
Park, K.
Lee, J.
机构：
[1] Dankook Univ Hosp, Cheonan, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.623
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
623
引用
收藏
页数：1
相关论文
共 50 条
  • [41] UFT +/- leucovorin as first line chemotherapy in ederly patients with advanced colorectal cancer.: The TTD Spanish experience.
    Sastre, J
    Abad, A
    Navarro, M
    Aranda, E
    Carralo, A
    Gallón, M
    Marcuello, E
    Rifá, J
    Arcusa, A
    Massuti, T
    Cerventes, A
    Antón, A
    Fernández-Martos, C
    Díaz-Rubio, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S73 - S73
  • [42] Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: A Korean single-center experience
    Park, SH
    Sung, JY
    Han, SH
    Baek, JH
    Oh, JH
    Bang, SM
    Cho, EK
    Shin, DB
    Lee, JH
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (09) : 531 - 535
  • [43] Prognostic Factors for Colorectal Cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study
    Takimoto, Rishu
    Kamigaki, Takashi
    Okada, Sachiko
    Matsuda, Eriko
    Ibe, Hiroshi
    Oguma, Eri
    Naitoh, Keiko
    Makita, Kaori
    Goto, Shigenori
    ANTICANCER RESEARCH, 2019, 39 (08) : 4525 - 4532
  • [44] Bevacizumab in combination with chemotherapy: First-line treatment of patients with metastatic colorectal cancer
    Hochster, Howard S.
    SEMINARS IN ONCOLOGY, 2006, 33 (05) : S8 - S14
  • [45] Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial
    Kim, TW
    Kang, WK
    Chang, HM
    Park, JO
    Ryoo, BY
    Ahn, JS
    Zang, DY
    Lee, KH
    Kang, YK
    Kim, SR
    Kim, HK
    ACTA ONCOLOGICA, 2005, 44 (03) : 230 - 235
  • [46] Capecitabine with cisplatin or with oxaliplatin in first-line chemotherapy in patients with metastatic gastric carcinoma (mGC): Single-center experience
    Narimanov, Mekhri
    Fedyanin, Mikhail
    Zarkua, Varlam
    Tryakin, Alexey
    Tjulandin, Sergel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study
    Bamias, Aristotelis
    Tzannis, Kimon
    Zakopoulou, Roubini
    Sakellakis, Minas
    Dimitriadis, John
    Papatheodoridi, Alkistis
    Rallidis, Loukianos
    Halvatsiotis, Panagiotis
    Tsiara, Anna
    Kaparelou, Maria
    Kostouros, Efthymios
    Barbarousi, Despina
    Koutsoukos, Konstantinos
    Fragiadis, Evangelos
    Dellis, Athanasios E.
    Anastasiou, Ioannis
    Stravodimos, Konstantinos
    Pinitas, Alexandros
    Papatsoris, Athanasios
    Adamakis, Ioannis
    Varkarakis, Ioannis
    Fragoulis, Charalampos
    Pagoni, Stamatina
    Matsouka, Charis
    Skolarikos, Andreas
    Mitropoulos, Dionysios
    Doumas, Konstantinos
    Deliveliotis, Charalampos
    Constantinides, Constantinos
    Dimopoulos, Meletios-Athanasios
    CURRENT ONCOLOGY, 2022, 29 (09) : 6077 - 6090
  • [48] A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
    Kang, H. J.
    Chang, H. M.
    Kim, T. W.
    Ryu, M-H
    Sohn, H-J
    Yook, J. H.
    Oh, S. T.
    Kim, B. S.
    Lee, J-S
    Kang, Y-K
    BRITISH JOURNAL OF CANCER, 2008, 98 (02) : 316 - 322
  • [49] A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
    H J Kang
    H M Chang
    T W Kim
    M-H Ryu
    H-J Sohn
    J H Yook
    S T Oh
    B S Kim
    J-S Lee
    Y-K Kang
    British Journal of Cancer, 2008, 98 : 316 - 322
  • [50] Cetuximab single-agent activity in refractory metastatic colorectal cancer: Single-center experience.
    Mirtsching, B
    Headlee, C
    Beasley, S
    Teel, C
    Jackson, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 294S - 294S
12345